Dow Jones Top Company Headlines at 9 am ET: Wegovy Maker Novo Looks to New Drugs to Combat Lilly, but Investors are Unconvinced | Paramount ...

Dow Jones
Sep 21

Wegovy Maker Novo Looks to New Drugs to Combat Lilly, but Investors Are Unconvinced

Shares in the company fell more than 4% as its CEO laid out plans for new blockbuster drugs in the next few years.

----

Paramount Discussed $1.5 Billion California Investment to Clear Merger Hurdle

The company has discussed a series of concessions as part of advanced settlement talks with a coalition of state attorneys general, hoping to clear a path for its $81 billion Warner Bros. deal.

----

Priority Technology CEO to Take Firm Private in $1.6 Billion Deal

The payment-technology company agreed to be taken private by an investor group led by its chair and chief executive, Thomas Priore, in a deal with an enterprise value of around $1.6 billion.

----

How Harley-Davidson, an American Icon, Became a Tariff Punching Bag

The U.S. motorcycle maker's politically sensitive profile keeps it on the tariff payback list.

----

Google Fined $463 Million By Irish Data Watchdog Over Location Data Handling

Ireland's Data Protection Commission said Monday that Google infringed the EU's General Data Protection Regulation following a 2020 investigation into the company.

----

Nvidia to Support Scale-Up of Autonomous Trucks at Sweden's Einride

The company operates hundreds of electric trucks for major shipping clients across the U.S., Europe and the Middle East, and expects demand to increase to up to 2,000 vehicles by 2028.

----

Disney Theme Parks Defy Industry Slump With Price Cuts and Promotions

Special deals helped boost attendance in Florida and California while traffic thins out at competitors Universal and SeaWorld.

----

Anthropic Shifts Planned IPO to November

Investors had expected the Claude maker to debut in October. The AI industry has been grappling with calls to slow down its pace of development.

----

Ipsen Falls After Early Launch of U.S. Generic Rival

Stock fell sharply after the U.S. Food and Drug Administration approved a generic competitor to its flagship Somatuline hormone drug earlier than expected.

----

China is chasing SpaceX and setting its sights on the global space economy

Chinese space-technology players are looking to grow their reach, experts say. They're closing in on Elon Musk and company.

----

Volvo Recruits a Top VW Executive to Steer Its Turnaround

Klaus Zellmer, whose Škoda brand posted profit margins that rival those of BMW and Mercedes, will replace Håkan Samuelsson as Volvo pushes new models.

----

Ken Griffin's New Miami Headquarters on Pause After Construction Accident

A fallen drill rig crushed three vehicles, and authorities are investigating what caused the accident at Griffin's Citadel project.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10